Accession Number: | 0001209191-21-041227 |
Date: | 2021-06-15 |
Issuer: | BIOATLA, INC. (BCAB) |
Original Submission Date: |
MORAN SUSAN
C/O BIOATLA, INC. 11085 TORREYANA ROAD
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 39.64 | 2021-06-15 | deemed execution date | A | 12,307 (a) | 2031-06-15 | common stock 12,307 | $39.64 | 12,307 | direct |
ID | footnote |
---|---|
f1 | 100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) june 15, 2022 or (b) the next annual meeting of stockholders, subject to the optionee continuing to provide services to the company through the vesting date; provided however, that if the optionee ceases to provide services to the company prior to the vesting date for any reason other than cause (as defined in the plan), such option will vest on a pro-rata basis determined by multiplying the total number of shares by a fraction, the numerator of which is the number of whole months that the optionee provided services to the company since the date that the award was granted, and the denominator of which is 12 months. |